We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SCENIHR Recommends Phased Approach to Risk Evaluation of Nanomaterials
The item has been added to your shopping cart.
SCENIHR Recommends Phased Approach to Risk Evaluation of Nanomaterials
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk to avoid unnecessary testing, an expert committee of the European Commission recommends.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor